Alpine Immune Sciences Inc (ALPN)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-04-29 | 2024-04-25 | S Sale | Non-Executive Director |
19
-0.0%
64.57USD 1,227 |
19 -0.0% | 64.57 | USD 1,227 | |
| 2024-01-29 | 2024-01-26 | PS Planned sale |
See Remarks Officer |
44,000
-100.0%
25.00USD 1,100,000 |
44,000 -100.0% | 25.00 | USD 1,100,000 | |
| 2024-01-29 | 2024-01-26 | PS Planned sale |
See Remarks Officer |
73,764
-100.0%
22.31USD 1,645,830 |
73,764 -100.0% | 22.31 | USD 1,645,830 | |
| 2024-01-29 | 2024-01-25 | PS Planned sale |
See Remarks Officer |
236
-100.0%
22.00USD 5,192 |
236 -100.0% | 22.00 | USD 5,192 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
139,166
-34.5%
18.32USD 2,549,521 |
139,166 -34.5% | 18.32 | USD 2,549,521 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
1,195,683
-34.5%
18.32USD 21,904,913 |
1,195,683 -34.5% | 18.32 | USD 21,904,913 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
3,128
-0.8%
19.82USD 61,997 |
3,128 -0.8% | 19.82 | USD 61,997 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
26,872
-0.8%
19.82USD 532,603 |
26,872 -0.8% | 19.82 | USD 532,603 | |
| 2023-12-29 | 2023-12-28 | PS Planned sale |
Executive Chairman and CEO Executive Director |
1,016
-100.0%
20.04USD 20,362 |
1,016 -100.0% | 20.04 | USD 20,362 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
139,166
-34.5%
18.32USD 2,549,521 |
139,166 -34.5% | 18.32 | USD 2,549,521 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
1,195,683
-34.5%
18.32USD 21,904,913 |
1,195,683 -34.5% | 18.32 | USD 21,904,913 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
3,128
-0.8%
19.82USD 61,997 |
3,128 -0.8% | 19.82 | USD 61,997 | |
| 2023-12-29 | 2023-12-28 | S Sale | Non-Executive Director |
26,872
-0.8%
19.82USD 532,603 |
26,872 -0.8% | 19.82 | USD 532,603 | |
| 2023-12-29 | 2023-12-27 | S Sale | Non-Executive Director |
18,922
-4.4%
19.96USD 377,683 |
18,922 -4.4% | 19.96 | USD 377,683 | |
| 2023-12-29 | 2023-12-27 | S Sale | Non-Executive Director |
162,576
-4.4%
19.96USD 3,245,017 |
162,576 -4.4% | 19.96 | USD 3,245,017 | |
| 2023-12-29 | 2023-12-27 | S Sale | Non-Executive Director |
18,922
-4.4%
19.96USD 377,683 |
18,922 -4.4% | 19.96 | USD 377,683 | |
| 2023-12-29 | 2023-12-27 | S Sale | Non-Executive Director |
162,576
-4.4%
19.96USD 3,245,017 |
162,576 -4.4% | 19.96 | USD 3,245,017 | |
| 2023-12-27 | 2023-12-27 | PS Planned sale |
Executive Chairman and CEO Executive Director |
29,573
-100.0%
20.04USD 592,717 |
29,573 -100.0% | 20.04 | USD 592,717 | |
| 2023-12-27 | 2023-12-26 | PS Planned sale |
Executive Chairman and CEO Executive Director |
24,486
-100.0%
20.22USD 495,217 |
24,486 -100.0% | 20.22 | USD 495,217 | |
| 2023-12-27 | 2023-12-22 | PS Planned sale |
Executive Chairman and CEO Executive Director |
37,825
-100.0%
20.43USD 772,595 |
37,825 -100.0% | 20.43 | USD 772,595 | |
| 2023-12-21 | 2023-12-19 | PS Planned sale |
See Remarks Officer |
15,213
-100.0%
19.21USD 292,222 |
15,213 -100.0% | 19.21 | USD 292,222 | |
| 2023-12-21 | 2023-12-19 | PS Planned sale |
Executive Chairman and CEO Executive Director |
2,402
-100.0%
20.01USD 48,064 |
2,402 -100.0% | 20.01 | USD 48,064 | |
| 2023-12-18 | 2023-12-18 | PS Planned sale |
See Remarks Officer |
1,800
-100.0%
19.00USD 34,203 |
1,800 -100.0% | 19.00 | USD 34,203 | |
| 2023-12-18 | 2023-12-15 | PS Planned sale |
See Remarks Officer |
45,387
-100.0%
19.09USD 866,383 |
45,387 -100.0% | 19.09 | USD 866,383 | |
| 2023-12-18 | 2023-12-14 | PS Planned sale |
See Remarks Officer |
11,600
-100.0%
19.00USD 220,406 |
11,600 -100.0% | 19.00 | USD 220,406 | |
| 2023-12-12 | 2023-12-12 | PS Planned sale |
Executive Chairman and CEO Executive Director |
8,613
-100.0%
17.32USD 149,138 |
8,613 -100.0% | 17.32 | USD 149,138 | |
| 2023-12-12 | 2023-12-12 | PS Planned sale |
Executive Chairman and CEO Executive Director |
32,450
-100.0%
17.32USD 561,888 |
32,450 -100.0% | 17.32 | USD 561,888 | |
| 2023-12-12 | 2023-12-11 | PS Planned sale |
Executive Chairman and CEO Executive Director |
68,870
-68.0%
17.26USD 1,189,027 |
68,870 -68.0% | 17.26 | USD 1,189,027 | |
| 2023-12-12 | 2023-12-08 | PS Planned sale |
Executive Chairman and CEO Executive Director |
8,067
-7.4%
17.08USD 137,784 |
8,067 -7.4% | 17.08 | USD 137,784 | |
| 2023-12-06 | 2023-12-06 | PS Planned sale |
See Remarks Officer |
6,446
-100.0%
16.08USD 103,650 |
6,446 -100.0% | 16.08 | USD 103,650 | |
| 2023-12-06 | 2023-12-05 | PS Planned sale |
See Remarks Officer |
418
-100.0%
16.01USD 6,694 |
418 -100.0% | 16.01 | USD 6,694 | |
| 2023-12-06 | 2023-12-04 | PS Planned sale |
See Remarks Officer |
63,947
-100.0%
16.06USD 1,026,887 |
63,947 -100.0% | 16.06 | USD 1,026,887 | |
| 2023-12-01 | 2023-11-30 | PS Planned sale |
See Remarks Officer |
700
-100.0%
16.00USD 11,200 |
700 -100.0% | 16.00 | USD 11,200 | |
| 2023-11-14 | 2023-11-09 | B Purchase |
Decheng Capital Global Healthcare Fund (Master), LP Large shareholder |
375,000
+27.6%
12.50USD 4,687,500 |
375,000 +27.6% | 12.50 | USD 4,687,500 | |
| 2023-11-14 | 2023-11-09 | B Purchase | Non-Executive Director Large shareholder |
375,000
+27.6%
12.50USD 4,687,500 |
375,000 +27.6% | 12.50 | USD 4,687,500 | |
| 2023-11-08 | 2023-11-06 | PS Planned sale |
See Remarks Officer |
18,003
-100.0%
16.03USD 288,554 |
18,003 -100.0% | 16.03 | USD 288,554 | |
| 2022-02-15 | 2022-02-11 | B Purchase |
Frazier Life Sciences VIII, L.P. Large shareholder |
112,665
+8.2%
7.10USD 799,989 |
112,665 +8.2% | 7.10 | USD 799,989 | |
| 2022-01-04 | 2021-12-31 | S Sale |
Senior VP and CFO Officer |
17,013
-70.8%
13.92USD 236,756 |
17,013 -70.8% | 13.92 | USD 236,756 | |
| 2021-09-17 | 2021-09-16 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
6,768
-4.2%
10.00USD 67,696 |
6,768 -4.2% | 10.00 | USD 67,696 | |
| 2021-09-17 | 2021-09-15 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
3,484
-2.1%
10.00USD 34,840 |
3,484 -2.1% | 10.00 | USD 34,840 | |
| 2021-06-29 | 2021-06-28 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
3,479
-2.1%
10.00USD 34,792 |
3,479 -2.1% | 10.00 | USD 34,792 | |
| 2021-06-29 | 2021-06-25 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
9,473
-5.3%
10.01USD 94,865 |
9,473 -5.3% | 10.01 | USD 94,865 | |
| 2021-03-08 | 2021-03-05 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
10,000
-3.6%
12.99USD 129,875 |
10,000 -3.6% | 12.99 | USD 129,875 | |
| 2021-03-08 | 2021-03-04 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
10,000
-3.4%
13.01USD 130,108 |
10,000 -3.4% | 13.01 | USD 130,108 | |
| 2021-02-03 | 2021-02-02 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
10,000
-3.3%
11.74USD 117,381 |
10,000 -3.3% | 11.74 | USD 117,381 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
7,021
-2.3%
13.20USD 92,698 |
7,021 -2.3% | 13.20 | USD 92,698 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
Executive Chairman and CEO Executive Director Large shareholder |
2,979
-1.0%
12.07USD 35,968 |
2,979 -1.0% | 12.07 | USD 35,968 | |
| 2020-12-30 | 2020-12-28 | S Sale | Non-Executive Director Large shareholder |
600,000
-16.3%
14.25USD 8,550,000 |
600,000 -16.3% | 14.25 | USD 8,550,000 | |
| 2020-12-30 | 2020-12-28 | S Sale | Non-Executive Director Large shareholder |
600,000
-16.3%
14.25USD 8,550,000 |
600,000 -16.3% | 14.25 | USD 8,550,000 | |
| 2020-11-23 | 2020-11-19 | B Purchase | Non-Executive Director |
10,000
+66.7%
8.03USD 80,300 |
10,000 +66.7% | 8.03 | USD 80,300 | |
| 2019-06-03 | 2019-05-30 | B Purchase |
Senior VP and CFO |
10,000
+inf%
4.95USD 49,500 |
10,000 +inf% | 4.95 | USD 49,500 | |
| 2019-02-12 | 2019-02-08 | S Sale | Large shareholder |
25,000
-15.4%
5.85USD 146,245 |
25,000 -15.4% | 5.85 | USD 146,245 | |
| 2019-01-23 | 2019-01-18 | B Purchase | Non-Executive Director Large shareholder |
372,439
+11.3%
5.37USD 1,999,997 |
372,439 +11.3% | 5.37 | USD 1,999,997 | |
| 2019-01-23 | 2019-01-18 | B Purchase | Non-Executive Director Large shareholder |
372,439
+11.3%
5.37USD 1,999,997 |
372,439 +11.3% | 5.37 | USD 1,999,997 | |
| 2019-01-22 | 2019-01-18 | B Purchase |
Executive Chairman and CEO Executive Director Large shareholder |
190,875
+5.0%
5.37USD 1,024,999 |
190,875 +5.0% | 5.37 | USD 1,024,999 | |
| 2019-01-22 | 2019-01-18 | B Purchase | Non-Executive Director Large shareholder |
372,439
+16.9%
5.37USD 1,999,997 |
372,439 +16.9% | 5.37 | USD 1,999,997 | |
| 2019-01-22 | 2019-01-18 | B Purchase | Non-Executive Director Large shareholder |
190,875
+5.0%
5.37USD 1,024,999 |
190,875 +5.0% | 5.37 | USD 1,024,999 | |
| 2019-01-22 | 2019-01-18 | B Purchase | Large shareholder |
190,875
+5.0%
5.37USD 1,024,999 |
190,875 +5.0% | 5.37 | USD 1,024,999 | |
| 2019-01-22 | 2019-01-18 | B Purchase |
Frazier Life Sciences VIII, L.P. Large shareholder |
372,439
+16.9%
5.37USD 1,999,997 |
372,439 +16.9% | 5.37 | USD 1,999,997 | |
| 2017-06-22 | 2017-06-20 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
1,715
+0.9%
2.25USD 3,859 |
1,715 +0.9% | 2.25 | USD 3,859 | |
| 2017-06-22 | 2017-06-20 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
6,359
+0.9%
2.25USD 14,308 |
6,359 +0.9% | 2.25 | USD 14,308 | |
| 2017-06-22 | 2017-06-20 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
9,732
+0.9%
2.25USD 21,897 |
9,732 +0.9% | 2.25 | USD 21,897 | |
| 2017-06-07 | 2017-06-07 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
3,673
+1.9%
2.28USD 8,379 |
3,673 +1.9% | 2.28 | USD 8,379 | |
| 2017-06-07 | 2017-06-07 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
13,046
+1.9%
2.28USD 29,762 |
13,046 +1.9% | 2.28 | USD 29,762 | |
| 2017-06-07 | 2017-06-07 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
20,181
+1.9%
2.28USD 46,039 |
20,181 +1.9% | 2.28 | USD 46,039 | |
| 2017-06-07 | 2017-06-05 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
3,920
+2.0%
2.29USD 8,979 |
3,920 +2.0% | 2.29 | USD 8,979 | |
| 2017-06-07 | 2017-06-05 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
12,624
+1.8%
2.29USD 28,917 |
12,624 +1.8% | 2.29 | USD 28,917 | |
| 2017-06-07 | 2017-06-05 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
19,206
+1.8%
2.29USD 43,993 |
19,206 +1.8% | 2.29 | USD 43,993 | |
| 2017-06-01 | 2017-05-31 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
2,727
+1.4%
2.25USD 6,128 |
2,727 +1.4% | 2.25 | USD 6,128 | |
| 2017-06-01 | 2017-05-31 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
10,023
+1.5%
2.25USD 22,522 |
10,023 +1.5% | 2.25 | USD 22,522 | |
| 2017-06-01 | 2017-05-31 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
15,350
+1.5%
2.25USD 34,491 |
15,350 +1.5% | 2.25 | USD 34,491 | |
| 2017-06-01 | 2017-05-30 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
1,805
+1.0%
2.30USD 4,144 |
1,805 +1.0% | 2.30 | USD 4,144 | |
| 2017-06-01 | 2017-05-30 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
6,903
+1.0%
2.30USD 15,847 |
6,903 +1.0% | 2.30 | USD 15,847 | |
| 2017-06-01 | 2017-05-30 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
10,192
+1.0%
2.30USD 23,398 |
10,192 +1.0% | 2.30 | USD 23,398 | |
| 2017-05-19 | 2017-05-19 | B Purchase |
BVF PARTNERS L P/IL Large shareholder |
1,124
+0.6%
2.30USD 2,585 |
1,124 +0.6% | 2.30 | USD 2,585 |